One stock that might be an intriguing choice for investors right now is CoLucid Pharmaceuticals, Inc. CLCD. This is because this security in the Medical – Biomedical and Genetics space is seeing solid ...

CoLucid Pharmaceuticals, Inc. CLCD was a big mover last session, as the company saw its shares rise roughly 10% on the day. The move came on solid volume too with far more shares changing hands than ...

At close: 28 June at 6:07:38 pm GMT-4 ...

Towards the end of August, we published this piece detailing two major potential upside catalysts to keep an eye on early September. One of the companies we profiled was CoLucid Pharmaceuticals Inc ...

Colucid Pharmaceuticals Inc (NASDAQ: CLCD) is acting great. It popped 1.60, or 4%, to 40.10, on 251,610 shares traded. It's right up against key resistance. The prior high was 40.50, and on Monday the ...

A brief overview of the NASDAQ:CLCD financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance ...

The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research ...